查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190727

电外科发电机市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Electrosurgical Generators Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内，电外科发生器市场的复合年增长率为 6.9%。

虽然 COVID-19 不是一种外科疾病，但它对外科手术产生了相当大的影响。 手术羽流是产生热组织损伤的能量装置（包括电外科发电机）的产物。 病毒的结构和稳定性、手术室工作人员可能接触的剂量以及电外科设备产生烟雾的温度是影响手术烟雾中发现的病毒颗粒传染性的一些因素。 此类事件在疫情爆发时严重限制了电外科发电机在手术中的使用。

然而，电外科等微创手术 (MIS) 下引入的新安全指南将在 2021 年和 2022 年生效，并对市场增长产生积极影响。. 根据 2022 年 3 月发表在《外科内窥镜杂誌》(Journal of Surgical Endoscopy) 上的一份报告，采取了预防措施，以避免在每次剖腹手术期间将手术室工作人员暴露于潜在的病毒性手术羽流中。 因此，电外科手术期间的手术羽流安全措施帮助医生和患者在进行手术时尽量减少接触 COVID-19。 这些因素有助于市场在大流行后阶段的增长。 此外，根据分析，该市场很可能在未来两到三年内实现大流行前的增长。

此外，由于慢性病和老年人口的增加、对微创手术的需求增加以及电外科发电机的技术进步，电外科发电机市场有望增长。 例如，根据英国心臟基金会的 2022 年报告，英国约有 760 万人患有心臟和循环系统问题。 此外，由于人口老龄化和不断增长，以及影响心臟和循环系统的潜在疾病，这一数字可能会继续上升。 电外科发电机在心臟手术中发挥着重要作用，有助于切割组织和控制出血。 因此，心臟相关疾病负担的增加将在未来几年推动医疗环境中对电外科发电机的需求。

此外，关于电外科设备的新研究揭示了设备的安全性，有助于扩大市场。 例如，根据 Cristina Ibanez Jimenez 于 2022 年 2 月发布的一份研究报告，SynchroSeal 的 E-100 电外科发生器的多功能设计提供了增强的密封和切割能力，并具有可接受的安全性。 因此，新的研究将通过提供高效和安全的产品为市场做出贡献，并将在预测期内推动市场。 然而，与电外科相关的风险和严格的监管框架是阻碍市场增长的主要因素。

主要市场趋势

泌尿外科领域有望占据大部分市场份额

电外科手术是一种使用电流来切割、移除或破坏组织并控制出血的手术。 它常用于各种泌尿外科手术，例如肾部分切除术、肾盂成形术、肾上腺切除术、根治性前列腺切除术和膀胱切除术。 由于电外科发电机的使用越来越多，预计泌尿外科市场将获得很大份额。

此外，癌症患者的增加也促进了这一领域的发展。 例如，美国癌症协会 2022 年 1 月发布的一份报告发现，美国男性膀胱癌新发病例为 61,700 例，女性为 19,480 例，估计有 81,180 例膀胱癌新发病例。 这表明这种疾病负担的严重性，增加了对肿瘤切除术的需求。 膀胱切除术是通过手术切除膀胱以治疗膀胱癌。

同样，根据上述消息来源，前列腺癌是美国男性中最常见的癌症之一。 据估计，2022 年将登记 268,490 例前列腺癌新病例。 因此，预计使用电外科发电机进行膀胱切除术和前列腺切除术的需求将增加，最终推动泌尿外科领域对发电机的市场需求。

此外，2021 年 9 月，奥林巴斯推出了其新型 POWERSEAL 系列先进双极手术能量产品中的第一款设备。 POWERSEAL 设备可用于多种形式的外科手术，包括泌尿外科手术。 因此，由于新产品的批准和推出，预计在预测期内对电外科发电机的需求将出现显着增长。

预计在预测期内北美将主导市场

由于拥有先进的医疗设施和先进的技术方法，预计北美电外科发生器市场将由美国主导。 预计技术进步将推动市场增长以及癌症等慢性病负担增加和老年人口增加等主要因素。

例如，加拿大癌症协会估计，到 2022 年底，加拿大将有 233,900 人被诊断出患有癌症，高于 2021 年的 229,200 人。 癌症患者的增加需要肿瘤切除术，这可以通过电外科手术来完成，预计这将在预测期内推动市场。

此外，根据 2022 BC 卫生局的数据，加拿大 90% 的皮肤肿瘤切除病例的手术等待时间估计为 15.2 週。 较长的开放手术等待时间将增加对电外科等微创手术的需求，从而推动医疗机构对电外科发电机的需求。

此外，主要市场参与者的新产品批准和推出正在推动市场增长。 例如，2022 年 1 月，Ethicon 的 Megadyne Electrosurgical Generator 获得了美国 FDA 的批准。 它旨在用作各种开放式和腹腔镜手术的通用电外科发生器。 因此，该地区对电外科发电机的新批准将反过来扩大该设备的多种应用范围，并帮助市场在研究期间增长。

竞争格局

电外科发生器市场较为分散。 世界领先的公司製造了大部分电外科发电机。 拥有更多研究资源和更好分销网络的市场领导者已在行业中为自己开闢了一席之地。 主要参与者包括 Medtronic、ConMed Corporation、Johnson & Johnson Services (Ethicon, Inc)、Olympus Corporation、B. Brown SE、Aspen Surgical (Simmarie Surgical Inc)、Medrange, Inc. 和 Applied Medical Resources, Inc.、KARL STORZ SE & Co。 KG, BD (Becton Dickinson & Company)，美国医疗创新公司。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 调查先决条件和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 慢性病和日益老龄化的人口
    • 对微创手术的需求增加
    • 电外科发电机的技术进步
  • 市场製约因素
    • 与电外科相关的风险
    • 严格的监管框架
  • 行业吸引力 - 波特五力分析
    • 新进入者的威胁
    • 买家的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按类型
    • 单极
    • 双相
    • 两者
  • 通过申请
    • 普通外科
    • 泌尿科
    • 神经病学
    • 妇科
    • 胃肠病学
    • 其他用途（心脏病学、整形外科、皮肤科）
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户（诊所、创伤中心等）
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Medtronic
    • CONMED Corporation
    • Johnson & Johnson Services, Inc.（Ethicon, Inc.）
    • Olympus Corporation
    • B. Braun SE
    • Aspen Surgical（Symmetry Surgical Inc.）
    • Medrange Corporation
    • Applied Medical Resources Corporation
    • KARL STORZ SE & Co. KG
    • BD（Becton, Dickinson and Company）
    • US Medical Innovations

第7章 市场机会今后动向

简介目录
Product Code: 93045

The electrosurgical generators market is expected to register a CAGR of 6.9% over the forecast period.

Although COVID-19 was not a surgical disease, it considerably impacted surgical practice. A surgical plume is a by-product of energy devices, including electrosurgical instruments, that creates thermal tissue damage. The structure and stability of the virus, the possible dose to which operating room staff exposed it, and the temperature at which the electrosurgical device produced the smoke were a few factors that affected the infectiousness of viral particles discovered in the surgical plume. Such instances significantly restricted the use of electrosurgical generators in surgical operations amid the outbreak.

However, the introduction of newer guidelines for safety under minimally invasive surgery (MIS), like electrosurgical procedures, was undertaken in the years 2021 and 2022, impacting the market's growth positively. As per the report published by the Journal of Surgical Endoscopy in March 2022, for every open procedure, precautions were taken to keep the operating room staff from being exposed to the surgical plume, which may include viruses. Hence, the safety precautions for surgical plumes during electrosurgical procedures helped physicians and patients perform the surgery with minimal exposure to COVID-19. Such factors have contributed to the market's growth in the post-pandemic phase. Furthermore, as per the analysis, the market is likely to achieve its pre-pandemic growth in the next two to three years.

In addition, the electrosurgical generator market is expected to grow due to the rise in chronic diseases and the geriatric population, increasing demands for minimally invasive surgeries, and technological advancements in electrosurgical units. For instance, according to the British Heart Foundation's 2022 report, approximately 7.6 million people in United Kingdom have heart and circulatory disorders. Moreover, with an aging and growing population, as well as underlying conditions affecting the heart and circulatory system, these numbers could keep rising. Electrosurgical generators play a vital role in cardiac surgeries, helping to cut the tissues and control bleeding. Thus, the increasing burden of heart-related disorders will, in turn, boost the demand for electrosurgical generators in healthcare settings over the coming years.

Furthermore, the new research studies on electrosurgical devices reveal the safety profile of the devices and help in the market's growth. For instance, as per the study report by Cristina Ibanez Jimenez in February 2022, SynchroSeal's multifunctional design with the E-100 electrosurgical generator provides enhanced sealing and transection capabilities with an acceptable safety profile. Thus, the new studies help the market by providing efficient and safe products and will drive the market over the forecast period. However, the risks associated with electrosurgical procedures and stringent regulatory frameworks are the major factors hindering market growth.

Key Market Trends

Urology Segment Expected to Hold Major Market Shares

Electrosurgery is a procedure that uses an electric current to cut, remove, or destroy tissue and control bleeding. It is commonly used in various urologic surgeries, such as partial nephrectomy, pyeloplasty, adrenalectomy, radical prostatectomy, and cystectomy. With the increasing use of electrosurgical generators, the market segment for urology is expected to garner a substantial market share.

The rising cancer cases are also contributing to the segment's growth. For instance, as per the report published by the American Cancer Society in January 2022, an estimated 81,180 new cases of bladder cancer, with 61,700 in men and 19,480 in women, were registered in United States. This shows a high burden of the disease and increases the demand for the resection of the tumor. Cystectomy is a procedure in which the urinary bladder is removed surgically to treat bladder cancer.

Similarly, per the above source, prostate cancer is one of the most common cancers in American men. An estimated 268,490 new cases of prostate cancer were registered in 2022. Hence, the demand for cystectomy and prostatectomy using electrosurgical generators is expected to increase, which ultimately drives the market demand for generators in the urology segment.

Furthermore, in September 2021, Olympus launched its first devices in the new POWERSEAL family of advanced bipolar surgical energy products. The POWERSEAL devices can be used in numerous forms of surgical intervention, including urological surgical procedures. Hence with new product approvals and launches, the demand for electrosurgical generators is anticipated to observe significant growth over the forecast period.

North America Expected to Dominate the Market over the Forecast Period

The market for electrosurgical generators in North America is likely to be dominated by United States due to the region's sophisticated healthcare facilities and an advanced technology approach. The major factors, such as the increasing burden of chronic diseases like cancer and the growing geriatric population, along with technological advancements, are expected to fuel the market's growth.

For instance, the Canadian Cancer Society estimated 233,900 people in Canada to be diagnosed with cancer by the end of 2022, which is a high count compared to the 229,200 cases in 2021. The increase in cancer cases requires the resection of the tumors, which can be achieved using electrosurgical procedures and is thus expected to drive the market over the forecast period.

Furthermore, according to the Health Authorities in B.C. 2022, the surgical wait time for 90% of skin tumor removal cases in Canada is estimated at 15.2 weeks. Longer wait times for open surgeries will bolster the demand for minimally invasive surgeries such as electrosurgical procedures, boosting the demand for electrosurgical generators across healthcare facilities.

Moreover, the new product approvals and launches by the major market players are helping the market grow. For instance, in January 2022, Ethicon received United States FDA approval for the Megadyne Electrosurgical Generator. It is intended to be used as a general-purpose electrosurgical generator for a wide variety of open and laparoscopic procedures. Hence, the new approval of the electrosurgical generators in the region, in turn, increases the scope of the device towards multiple applications and helps the market to grow over the study period.

Competitive Landscape

The electrosurgical generator market is moderately fragmented. The global key players are manufacturing the majority of the electrosurgical generators. Market leaders who have greater resources for research and a better distribution network have carved out a place for themselves in the industry. Some of the major players include Medtronic, CONMED Corporation, Johnson & Johnson Services, Inc. (Ethicon, Inc.), Olympus Corporation, B. Braun SE, Aspen Surgical (Symmetry Surgical Inc.), Medrange Corporation, Applied Medical Resources Corporation, KARL STORZ SE & Co. KG, BD (Becton, Dickinson, and Company), and US Medical Innovations.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Chronic Diseases and Geriatric Population
    • 4.2.2 Increasing Demand for Minimally Invasive Surgeries
    • 4.2.3 Technological Advancements in Electrosurgical Units
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Electrosurgical Procedures
    • 4.3.2 Stringent Regulatory Frameworks
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Monopolar
    • 5.1.2 Bipolar
    • 5.1.3 Both
  • 5.2 By Application
    • 5.2.1 General Surgery
    • 5.2.2 Urology
    • 5.2.3 Neurology
    • 5.2.4 Gynecology
    • 5.2.5 Gastroenterology
    • 5.2.6 Other Applications (Cardiology, Plastic Surgery, and Dermatology)
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Other End-users (Clinics, Trauma Centers, among others)
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic
    • 6.1.2 CONMED Corporation
    • 6.1.3 Johnson & Johnson Services, Inc. (Ethicon, Inc.)
    • 6.1.4 Olympus Corporation
    • 6.1.5 B. Braun SE
    • 6.1.6 Aspen Surgical (Symmetry Surgical Inc.)
    • 6.1.7 Medrange Corporation
    • 6.1.8 Applied Medical Resources Corporation
    • 6.1.9 KARL STORZ SE & Co. KG
    • 6.1.10 BD (Becton, Dickinson and Company)
    • 6.1.11 US Medical Innovations

7 MARKET OPPORTUNITIES AND FUTURE TRENDS